Efficacy of Parenteral Nutrition Supplemented With Glutamine Dipeptide to Decrease Hospital Infections in Critically Ill Surgical Patients
Background: Nosocomial infections are an important cause of morbidity and mortality in the surgical intensive care unit (SICU). Clinical benefits of glutamine-supplemented parenteral nutrition may occur in hospitalized surgical patients, but efficacy data in different surgical subgroups are lacking....
Gespeichert in:
Veröffentlicht in: | JPEN. Journal of parenteral and enteral nutrition 2008-07, Vol.32 (4), p.389-402 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: Nosocomial infections are an important cause of
morbidity and mortality in the surgical intensive care unit (SICU). Clinical
benefits of glutamine-supplemented parenteral nutrition may occur in
hospitalized surgical patients, but efficacy data in different surgical
subgroups are lacking. The objective was to determine whether
glutamine-supplemented parenteral nutrition differentially affects nosocomial
infection rates in selected subgroups of SICU patients. Methods: This
was a double-blind, randomized, controlled study of alanyl-glutamine
dipeptide-supplemented parenteral nutrition in SICU patients requiring
parenteral nutrition and SICU care after surgery for pancreatic necrosis,
cardiac, vascular, or colonic surgery. Subjects (n = 59) received
isocaloric/isonitrogenous parenteral nutrition, providing 1.5 g/kg/d standard
glutamine-free amino acids (STD-PN) or 1.0 g/kg/d standard amino acids + 0.5
g/kg/d glutamine dipeptide (GLN-PN). Enteral feedings were advanced as
tolerated. Nosocomial infections were determined until hospital discharge.
Results: Baseline clinical/metabolic data were similar between
groups. Plasma glutamine concentrations were low in all groups and were
increased by GLN-PN. GLN-PN did not alter infection rates after pancreatic
necrosis surgery (17 STD-PN and 15 GLN-PN patients). In nonpancreatic surgery
patients (12 STD-PN and 15 GLN-PN), GLN-PN was associated with significantly
decreased total nosocomial infections (STD-PN 36 vs GLN-PN 13, P <
.030), bloodstream infections (7 vs 0, P < .01), pneumonias (16 vs
6, P < .05), and infections attributed to Staphylococcus
aureus (P < .01), fungi, and enteric Gram-negative bacteria
(each P < .05). Conclusions: Glutamine
dipeptide-supplemented parenteral nutrition did not alter infection rates
following pancreatic necrosis surgery but significantly decreased infections
in SICU patients after cardiac, vascular, and colonic surgery. |
---|---|
ISSN: | 0148-6071 1941-2444 |
DOI: | 10.1177/0148607108317880 |